TriVascular's Ovation iX Abdominal Stent Graft System Introduced in Europe

September 15, 2015—TriVascular Technologies, Inc. announced that the first European patients have been treated successfully with the Ovation iX “integrated exchange” abdominal stent graft system at Herz- und Gefäßzentrum Bad Bevensen in Germany and Watford General Hospital in the United Kingdom.

The Ovation iX system, which is based on the company’s Ovation platform, is designed to provide physicians with options for greater procedural consistency and ease of use. The Ovation iX abdominal system received European CE Mark approval and US Food and Drug Administration approval earlier this year. 

According to the company, the new system allows contralateral gate access either by retrograde cannulation or through a new, built-in crossover lumen. TriVascular’s crossover lumen technology is designed for easier and more predictable cannulation of the contralateral limb when needed. The company noted that cannulation of the contralateral limb has been a common procedural challenge during endovascular aortic aneurysm repair, especially when treating the growing number of patients with complex aortoiliac anatomy. 

Thomas Nolte, MD, Head of Vascular Surgery at Herz- und Gefasszentrum Bad Bevensen, commented in the company’s announcement, “The Ovation platform, based on its breadth of application and the strength of its clinical data, is my frontline device. The new Ovation iX delivery system allows me to deploy the Ovation stent graft with increased ease and predictability. The iX system is the latest delivery system improvement from TriVascular in what is now a 5-year experience with the Ovation platform in Germany.”

On September 17, Dr. Nolte will be joined by Prof. Eric Verhoeven, MD, Prof. Omke Teebken, MD, and Prof. Gotz Richter, MD, for a symposium on the Ovation iX at DGG, the annual Deutsche Gesellschaft für Gefäßchirurgie und Gefäßmedizin Congress, taking place in September 16–19 in Münster, Germany.